Cell Death and DiseaseCancer BiologyPeer-reviewed journal article
Arginine methylation coordinates with phosphorylation to regulate NADP+ synthesis
Yue ZhuiD, Wanjun ZhangiD, Qian Li, Mengxue HuiD, Xiaoke XingiD, Yanze LiiD, Hemeng Zhang, Yuanyuan ZhaoiD, Luojun CheniD, Chunmin Zhang, Yali CheniD, Juanjuan LiiD, Weijie QiniD, Suxia HaniD, Huadong PeiiD, Pingfeng ZhangiD, Feng YaoiD
Abstract
NADK is the sole cytosolic enzyme responsible for synthesizing NADP+ from NAD+ within cells. The homeostasis of NAD+/NADP+ is controlled by NADK, usually dysregulated in various cancers, yet the precise underlying regulatory mechanisms remain largely unknown. In this study, we discover that PRMT6 methylates NADK at R39, R41, and R45, resulting in the suppression of NADK kinase activity and NADP+ synthesis. Mutations of these sites promote cancer cell proliferation and tumor growth. PRMT6-mediated methylation of NADK coordinates with Akt-mediated phosphorylation to regulate NADK, which stimulates its activity to increase NADP+ production through relief of an autoinhibitory function inherent to its amino terminus. PRMT6 also inhibits NADK activity in a phosphorylation-independent manner. Furthermore, NADK methylation is upregulated by RB1/E2F pathway in high-fat diet mice. Downregulation of NADK methylation in HCC enhances NADP+ production to promote cancer development. Our findings illuminate the molecular regulatory mechanisms governing NAD+/NADP+ homeostasis, suggesting that the PRMT6-NADK axis emerges as a direct player in high energy state. Furthermore, our research suggests potential therapeutic targets through chemical and genetic interventions. SignificancePrevious studies revealed that phosphorylation of NADK activates its activity in response to nutrient or other signaling pathways. Here, we discovered that PRMT6 methylates NADK at residues R39, R41, and R45, leading to the suppression of NADK kinase activity and NADP+ synthesis. This PRMT6-mediated methylation works in conjunction with Akt-mediated phosphorylation to regulate NADK. Additionally, we found that NADK methylation is upregulated by the RB1/E2F pathway in mice on a high-fat diet. In hepatocellular carcinoma (HCC), the downregulation of NADK methylation enhances NADP+ production, thereby promoting cancer development. Our findings provide a significant breakthrough in understanding the regulation of NADK and its response to environmental factors.
- organism: mouse
- organism: human
- assay: proteomics
- research focus: cancer & tumor microenvironment
- research focus: cell signaling & trafficking
- research focus: metabolism & bioenergetics
- approach: experimental assay
- approach: wet-lab / biochemical assay
- Citations
- 1
- FWCI
- 0.00
- Field percentile
- top 45%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Palmitoylation-dependent activation of NADK promotes NADP+ synthesis and tumorigenesis
Luojun Chen, Wanjun Zhang, … Pingfeng Zhang·bioRxiv·Jul 24, 2025
- NADK upregulation is an essential metabolic adaptation that enables breast cancer metastatic colonization
D. Ilter, T. Schild, … A. P. Gomes·bioRxiv·Mar 25, 2022
- Tyrosine phosphorylation and dimerization cooperatively activate NAMPT to enable NAD+ synthesis in cancer
Johnvesly Basappa, Cosimo Lobello, … Mariusz A. Wasik·bioRxiv·Aug 17, 2026
- The mechanism of nicotinamide phosphoribosyltransferase whereby positive allosteric modulation elevates cellular NAD+
K. M. Ratia, Z. Shen, … G. R. J. Thatcher·bioRxiv·Oct 21, 2022
- Bacteria boost mammalian host NAD metabolism by engaging the deamidated biosynthesis pathway
- AMPK senses cellular levels of nicotinamide adenine dinucleotide
Niall Wilson, Yoana Rabanal‐Ruiz, … Viktor I. Korolchuk·bioRxiv·May 21, 2026